<!DOCTYPE html>
<html lang="en" dir="ltr">
    <head>
        <meta charset="utf-8">
        <link rel="stylesheet" href="/static/rendered_html/uslm.css">
        <link rel="stylesheet" href="/static/rendered_html/style.css">
        <script src="https://kit.fontawesome.com/2ce1080035.js" crossorigin="anonymous"></script>
        <script lang="text/javascript" src="/static/rendered_html/omni.js" defer></script>

        <!-- Table of Contents button section sheet. Would ideally be a working breadcrumb --> 
        <img src="../omni.jpg" alt="Omnibuster" style="width:100%">
        <ul class="breadcrumb" style="text-align:center">
            <!-- TODO GENERALIZE THIS --> 
            <li><a href="index.html"> Table of Contents</a></li>
            
                <li> Division A </a></li>
            
                <li> Title III </a></li>
            
                <li> Subtitle F </a></li>
            
                <li> Part I </a></li>
            
                <li> Section 3855 </a></li>
            
        </ul>


        <!-- <title> Omnibuster </title>
 -->
    </head>

    <body>
        <br><br><br>
        <div class="section">
            <div class="buttons">
                <div class="navbar">
                    <div>
                        <button onclick="highlightSelection();">Highlight Text</button>
                    </div>
                    <div>
                        <button onclick="annotateSelection();">[Not working] Annotate Text</button>
                    </div> 
                </div>
            </div>
            <p> 
                <section id="d3355e28402" identifier="/us/bill/116/hr/748/dA/tIII/stF/ptI/s3855" style="-uslm-lc:I650144"><num value="3855">SEC. 3855. </num><heading>ANNUAL UPDATE TO CONGRESS ON APPROPRIATE PEDIATRIC INDICATION FOR CERTAIN OTC COUGH AND COLD DRUGS.</heading><subsection class="indent0 fontsize10" id="d3355e28407" identifier="/us/bill/116/hr/748/dA/tIII/stF/ptI/s3855/a" style="-uslm-lc:I650120"><num style="-uslm-lc:emspace2" value="a">(a) </num><heading><inline class="small-caps">In General</inline>.—</heading><chapeau>Subject to subsection (c), the Secretary of Health and Human Services shall, beginning not later than 1 year after the date of enactment of this Act, annually submit to the Committee on Energy and Commerce of the House of Representatives and the Committee on Health, Education, Labor, and Pensions of the Senate a letter describing the progress of the Food and Drug Administration—</chapeau><paragraph class="indent1 fontsize10" id="d3355e28416" identifier="/us/bill/116/hr/748/dA/tIII/stF/ptI/s3855/a/1" style="-uslm-lc:I650122"><num style="-uslm-lc:emspace2" value="1">(1) </num><content>in evaluating the cough and cold monograph described in subsection (b) with respect to children under age 6; and</content>
</paragraph>
<paragraph class="indent1 fontsize10" id="d3355e28423" identifier="/us/bill/116/hr/748/dA/tIII/stF/ptI/s3855/a/2" style="-uslm-lc:I650122"><num style="-uslm-lc:emspace2" value="2">(2) </num><content>as appropriate, revising such cough and cold monograph to address such children through the order process under section 505G(b) of the Federal Food, Drug, and Cosmetic Act, as added by section 3851 of this subtitle.</content>
</paragraph>
</subsection>
<subsection class="indent0 fontsize10" id="d3355e28431" identifier="/us/bill/116/hr/748/dA/tIII/stF/ptI/s3855/b" style="-uslm-lc:I650120"><num style="-uslm-lc:emspace2" value="b">(b) </num><heading><inline class="small-caps">Cough and Cold Monograph Described</inline>.—</heading><content>The cough and cold monograph described in this subsection consists of the conditions under which nonprescription drugs containing antitussive, expectorant, nasal decongestant, or antihistamine active ingredients (or combinations thereof) are generally recognized as safe and effective, as specified in <a href="https://www.law.cornell.edu/cfr/text/21/t341" target="_blank"><ref href="/us/cfr/t21/pt341">part 341 of title 21, Code of Federal Regulations</ref></a> (as in effect immediately prior to the date of enactment of this Act), and included in an order deemed to be established under section 505G(b) of the Federal Food, Drug, and Cosmetic Act, as added by section 3851 of this subtitle.</content>
</subsection>
<subsection class="indent0 fontsize10" id="d3355e28445" identifier="/us/bill/116/hr/748/dA/tIII/stF/ptI/s3855/c" style="-uslm-lc:I650120"><num style="-uslm-lc:emspace2" value="c">(c) </num><heading><inline class="small-caps">Duration of Authority</inline>.—</heading><content>The requirement under subsection (a) shall terminate as of the date of a letter submitted by the Secretary of Health and Human Services pursuant to such subsection in which the Secretary indicates that the Food and Drug Administration has completed its evaluation and revised, in a final order, as applicable, the cough and cold monograph as described in subsection (a)(2).</content>
</subsection>
</section>
            </p>
        </div>  

        <!-- previous section -->
        <button onclick="location.href='section_s3854.html'" id="ls-btn-prev-sec" title="go to previous section">
            <i class="fas fa-angle-left"></i>
        </button>
        <!-- end previous section -->

        <!-- next section -->
        <button onclick="location.href='section_s3856.html'" id="ls-btn-next-sec" title="go to next section" data-ls-target-index="2">
            <i class="fas fa-angle-right"></i>
        </button>
        <!-- end next section -->

    </body>
